Artemisinin Combination Therapy Market Competitive Research And Precise Outlook 2021 To 2025 -Aspen Pharmacare Holdings Limited, - Calyx Chemicals and Pharmaceuticals Limited

Market Insights Reports released a new study on 2021-2025 Artemisinin Combination Therapy Market with 100+ data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis.

The Global Artemisinin Combination Therapy Market Report provides an in-depth assessment of the given sector’s current position and central factors. The study considers the present scenario of the Artemisinin Combination Therapy market and its market dynamics for the period 2021-2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Covid-19 Impact and Recovery Analysis:

The global Artemisinin Combination Therapy market report also includes the impact of the Covid-19 pandemic. Moreover, it offers an exhaustive analysis of aspects that will encounter the development of the market pre & post Covid-19 pandemic.

Click the link to Get a Free Exclusive Sample Copy of the Report:

https://www.marketinsightsreports.com/reports/01091744582/artemisinin-combination-therapy-market-growth-trends-and-forecast-2020-2025/inquiry?mode=69

Top Key Players in the Global Artemisinin Combination Therapy Market: - Aspen Pharmacare Holdings Limited, - Calyx Chemicals and Pharmaceuticals Limited, - Cipla, - Desano Inc, - Hovid Berhad, - Ipca Laboratories, - KPC Pharmaceuticals, - Guilin Pharmaceutical(Fosun Pharmaceutical ), - Novartis AG, - Sanofi

Market Overview

Artemisinin combination therapy (ACT) is used for the treatment of Plasmodium falciparum malaria. This market has been growing in recent years due to the high prevalence of malaria, especially in developing and under-developing countries. According to the World Malaria Report 2018 by World Health Organization (WHO), there were an estimated 219 million cases and nearly 435,000 related deaths in 2017 and most of the malaria cases were attributed to Plasmodium falciparum. Hence, high prevalence of malaria is driving the growth of this market. Other factors like increase in awareness initiatives by Governments and research for new anti-malarial drugs and therapies are also helping this market grow.

Key Market Trends

Artemether-Lumefantrine segment is expected to dominate the market in the forecast period.

Artemether-Lumefantrine is a combination of the two medications artemether and lumefantrine. It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine. The combination came into medical use in 1992. They were both developed in China. It is one of the drugs on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The World Health Organization recommends that uncomplicated Plasmodium falciparum malaria should be treated with an artemisinin- lumefantrine combination therapy. Artemether-lumefantrine is the most widely used Artemisinin Combination Therapy (ACT), accounting for 73% of global ACT procurement according to an article by Frank Kloprogge et al published in PLoS Medicine Journal 2018, which makes it one of the most widely used anti-infective agents in the world today.

Regional Analysis:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Inquiry for best Discount here:

https://www.marketinsightsreports.com/reports/01091744582/artemisinin-combination-therapy-market-growth-trends-and-forecast-2020-2025/discount?mode=69

The Middle East and Africa is one of the largest markets

According to the World Health Organization (WHO), there were an estimated 219 million cases of malaria worldwide in 2017, out of which WHO African Region carried a disproportionately high share of the global malaria burden. In 2017, the region contributed 92% of malaria cases and 93% of malaria deaths. The WHO Eastern Mediterranean Region was home for nearly 2% of the global malaria cases. Moreover, out of the total USD 2.7 billion investment in 2016 for the treatment and prevention of malaria, nearly 74% was spent in the WHO African Region.

Significant Features and Key Highlights of the Reports:

– Detailed overview of Artemisinin Combination Therapy Market
– Changing market dynamics of the industry
– In-depth market segmentation by Type, Application etc.
– Historical, current and projected market size in terms of volume and value.
– Recent industry trends and developments
– Competitive landscape of Artemisinin Combination Therapy Market
– Strategies of key players and product offerings
– Potential and niche segments/regions exhibiting promising growth.

Key questions answered

- Who are the Leading key players and what are their Key Business plans in the Global Artemisinin Combination Therapy market?
- What are the key concerns of the five forces analysis of the Global Artemisinin Combination Therapy market?
- What are different prospects and threats faced by the dealers in the Global Artemisinin Combination Therapy market?
- What are the strengths and weaknesses of the key vendors?

The research includes historic data from 2015 to 2020 and forecasts until 2025 which makes the reports an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Purchase this Report @:

https://www.marketinsightsreports.com/report/purchase/01091744582?mode=su?mode=69

Customization of this Report: This report can be customized as per your needs for additional data up to 5 companies or countries or 40 analyst hours.

Please contact our sales professional (sales@marketinsightsreports.com), we will ensure you obtain the report which works for your needs.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234 | +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com

ABOUT US:
Market Insights Reports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. Market Insights Reports provides global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.